160 related articles for article (PubMed ID: 38625602)
1. Defining distal splenopancreatectomy by the mesopancreas.
Safi SA; Alexander A; Neuhuber W; Haeberle L; Rehders A; Luedde T; Esposito I; Fluegen G; Knoefel WT
Langenbecks Arch Surg; 2024 Apr; 409(1):127. PubMed ID: 38625602
[TBL] [Abstract][Full Text] [Related]
2. Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival.
Safi SA; Haeberle L; Fluegen G; Lehwald-Tywuschik N; Krieg A; Keitel V; Luedde T; Esposito I; Rehders A; Knoefel WT
Pancreatology; 2021 Jun; 21(4):787-795. PubMed ID: 33775563
[TBL] [Abstract][Full Text] [Related]
3. Pre-Operative MDCT Staging Predicts Mesopancreatic Fat Infiltration-A Novel Marker for Neoadjuvant Treatment?
Safi SA; Haeberle L; Heuveldop S; Kroepil P; Fung S; Rehders A; Keitel V; Luedde T; Fuerst G; Esposito I; Ziayee F; Antoch G; Knoefel WT; Fluegen G
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503170
[No Abstract] [Full Text] [Related]
4. Neoadjuvant Treatment Lowers the Risk of Mesopancreatic Fat Infiltration and Local Recurrence in Patients with Pancreatic Cancer.
Safi SA; Haeberle L; Rehders A; Fung S; Vaghiri S; Roderburg C; Luedde T; Ziayee F; Esposito I; Fluegen G; Knoefel WT
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008232
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma.
Sahakyan MA; Verbeke CS; Tholfsen T; Ignjatovic D; Kleive D; Buanes T; Lassen K; Røsok BI; Labori KJ; Edwin B
Ann Surg Oncol; 2022 Jan; 29(1):366-375. PubMed ID: 34296358
[TBL] [Abstract][Full Text] [Related]
6. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data.
Weyhe D; Obonyo D; Uslar VN; Stricker I; Tannapfel A
PLoS One; 2021; 16(3):e0248633. PubMed ID: 33735191
[TBL] [Abstract][Full Text] [Related]
8. Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma.
Jamiyan T; Shiraki T; Kurata Y; Ichinose M; Kubota K; Imai Y
World J Surg Oncol; 2020 Jun; 18(1):137. PubMed ID: 32571348
[TBL] [Abstract][Full Text] [Related]
9. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
Klaiber U; Schnaidt ES; Hinz U; Gaida MM; Heger U; Hank T; Strobel O; Neoptolemos JP; Mihaljevic AL; Büchler MW; Hackert T
Ann Surg; 2021 Jan; 273(1):154-162. PubMed ID: 30921051
[TBL] [Abstract][Full Text] [Related]
11. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.
Pine JK; Haugk B; Robinson SM; Darne A; Wilson C; Sen G; French JJ; White SA; Manas DM; Charnley RM
Pancreatology; 2020 Apr; 20(3):537-544. PubMed ID: 31996296
[TBL] [Abstract][Full Text] [Related]
12. Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): clinically relevant or just academic?
Gebauer F; Tachezy M; Vashist YK; Marx AH; Yekebas E; Izbicki JR; Bockhorn M
World J Surg; 2015 Feb; 39(2):493-9. PubMed ID: 25270344
[TBL] [Abstract][Full Text] [Related]
13. Contemporary Reappraisal of Intraoperative Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Review.
Datta J; Willobee BA; Ryon EL; Shah MM; Drebin JA; Kooby DA; Merchant NB
JAMA Surg; 2021 May; 156(5):489-495. PubMed ID: 33533898
[TBL] [Abstract][Full Text] [Related]
14. Effect of resection margin status on recurrence pattern and survival in distal pancreatectomy for left-sided pancreatic ductal adenocarcinoma.
Kwon J; Lee SR; Park SY; Lee JH; Song KB; Hwang DW; Shin JH; Kim SC
J Hepatobiliary Pancreat Sci; 2023 May; 30(5):633-643. PubMed ID: 36380718
[TBL] [Abstract][Full Text] [Related]
15. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
[TBL] [Abstract][Full Text] [Related]
16. Microscopically positive (R1) resections do not affect survival in pancreatic head cancer.
Mois E; Graur F; Al-Hajjar N; Zaharie F; Bartos A; Bodea R; Zaharie T; Rusu I; Iancu C
Ann Ital Chir; 2017; 88():491-496. PubMed ID: 29339587
[TBL] [Abstract][Full Text] [Related]
17. Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.
Schmocker RK; Delitto D; Wright MJ; Ding D; Cameron JL; Lafaro KJ; Burns WR; Wolfgang CL; Burkhart RA; He J
J Am Coll Surg; 2021 Apr; 232(4):405-413. PubMed ID: 33338577
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of margin clearance in total and distal pancreatectomy specimens with pancreatic ductal adenocarcinoma in a Danish population-based nationwide study.
Aaquist T; Fristrup CW; Hasselby JP; Hamilton-Dutoit S; Eld M; Pfeiffer P; Mortensen MB; Detlefsen S
Pathol Res Pract; 2024 Feb; 254():155077. PubMed ID: 38277754
[TBL] [Abstract][Full Text] [Related]
19. Impact of resection margin status on survival in advanced N stage pancreatic cancer - a multi-institutional analysis.
Teske C; Stimpel R; Distler M; Merkel S; Grützmann R; Bolm L; Wellner U; Keck T; Aust DE; Weitz J; Welsch T
Langenbecks Arch Surg; 2021 Aug; 406(5):1481-1489. PubMed ID: 33712875
[TBL] [Abstract][Full Text] [Related]
20. Surgical margin clearance and extended chemotherapy defines survival for synchronous oligometastatic liver lesions of the ductal adenocarcinoma of the pancreas.
Safi SA; Fluegen G; Rehders A; Haeberle L; Fung S; Keitel V; Krieg A; Knoefel WT; Lehwald-Tywuschik N
Int J Clin Oncol; 2021 Oct; 26(10):1911-1921. PubMed ID: 34132929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]